MiR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells in lupus nephritis mice through HMGB1/NF-κB signaling pathway

doi:10.11958/20253169

Abstract

Abstract:

Objective To explore the regulatory mechanism of microRNA (miR)-181a-5p on the proliferation and apoptosis of glomerular mesangial cells in mice with lupus nephritis (LN) through the high mobility group protein box 1 (HMGB1)/nuclear factor kappa B (NF-κB) signaling pathway. Methods LN mouse mesangial cells were isolated and cultured in vitro, and divided into the blank group, the mimics-NC group, the miR-181a-5p mimics group, the Si-NC group, the Si-HMGB1 group (transfected with Si-HMGB1), the mimics-NC+pcDNA-NC group, the miR-181a-5p mimics+pcDNA-NC group, the mimics-NC+pcDNA-HMGB1 group and the miR-181a-5p mimics+pcDNA-HMGB1 group. MRL/MPJ mouse mesangial cells were isolated and cultured in vitro as the control group. qRT-PCR method was implemented to measure the mRNA expression levels of miR-181a-5p and HMGB1 in cells. Dual-luciferase experiments were performed to verify the targeting relationship of miR-181a-5p to HMGB1. CCK-8 method and flow cytometry were implemented to measure cell proliferation and apoptosis, respectively. Western blot assay was performed to measure the protein expression levels of HMGB1, human inhibitor of nuclear factor κB-α (IκB-α) and NF-κB p65 in cells. Results There was a targeting relationship between miR-181a-5p and HMGB1. Compared with the control group, the cell proliferation rate, HMGB1 and NF-κB p65 protein expression were obviously increased in the blank group, and the miR-181a-5p and IκB-α expression were obviously decreased (P<0.05). Compared with the mimics-NC group, the cell proliferation rate, HMGB1 and NF-κB p65 protein expression were obviously decreased in the miR-181a-5p mimics group, and the miR-181a-5p and IκB-α expression were obviously increased (P<0.05). Compared with the Si-NC group, the cell proliferation rate, HMGB1 and NF-κB p65 protein expression were obviously decreased in the Si-HMGB1 group, and the IκB-α expression was obviously increased (P<0.05). The overexpression of HMGB1 was able to reverse the inhibitory effect of up-regulated miR-181a-5p on the excessive proliferation of glomerular mesangial cells in LN mice (P<0.05). Conclusion Overexpression of miR-181a-5p can inhibit the excessive proliferation of glomerular mesangial cells in LN mice, which may be related to the inhibition of HMGB1/NF-κB signaling pathway.

Key words: lupus nephritis, microRNAs, HMGB1 protein, NF-kappa B, mesangial cells, cell proliferation, apoptosis

CLC Number:

R593.242

Figures/Tables 9

References 18

[1]	SALES G, MACEDO N J, REIS NETO E, et al. Current treatment of lupus nephritis:an overview of the new guidelines[J]. J Bras Nefrol, 2025, 47(4):e20250092. doi:10.1590/2175-8239-JBN-2025-0092en.
[2]	PAN F, LU Y, YANG H. Panax notoginseng saponins treat steroid-resistant lupus nephritis by inhibiting macrophage-derived exosome-induced injury in glomerular endothelial cells via the mitochondrial autophagy-NLRP3 pathway[J]. J Ethnopharmacol, 2025, 343:119475. doi:10.1016/j.jep.2025.119475.
[3]	DONG C, WU M, LIU H, et al. Breaking the cycle:immune complexes,complement activation,and novel immunotherapies in lupus nephritis[J]. Front Immunol, 2025, 16:1624850. doi:10.3389/fimmu.2025.1624850.
[4]	ZHAO H, YAN Y, ZHANG L, et al. DNA molecular computing with weighted signal amplification for cancer miRNA biomarker diagnostics[J]. Adv Sci (Weinh), 2025, 12(22):e2416490. doi:10.1002/advs.202416490.
[5]	SHADBAD M A, BARADARAN B. hsa-miR-181a-5p inhibits glioblastoma development via the MAPK pathway:in-silico and in-vitro study[J]. Oncol Res, 2024, 32(12):1949-1958. doi:10.32604/or.2024.051569.
[6]	ZHOU Y, LONG M Y, CHEN Z Q, et al. Downregulation of miR-181a-5p alleviates oxidative stress and inflammation in coronary microembolization-induced myocardial damage by directly targeting XIAP[J]. J Geriatr Cardiol, 2021, 18(6):426-439. doi:10.11909/j.issn.1671-5411.2021.06.007.
[7]	ZHOU L, YUAN X, HU Y, et al. Blockade of HMGB1 reduces inflammation and pruritus in atopic dermatitis by inhibiting skin fibroblasts activation[J]. Int Arch Allergy Immunol, 2024, 185(2):170-181. doi:10.1159/000534568.
[8]	ZHAO Z, LI J, SONG N, et al. Buzhong Yiqi decoction improves inflammation and oxidative damage in autoimmune thyroiditis by inhibiting apoptosis via the SIRT1-mediated Nrf2/NF-κB axis[J]. J Ethnopharmacol, 2025, 351:119967. doi:10.1016/j.jep.2025.119967.
[9]	阳晓, 叶任高, 陈伟英, 等. 慢性移植物抗宿主病狼疮样肾炎小鼠模型的研制[J]. 中华肾脏病杂志, 2000, 16(5):277-281.
	YANG X, YE R G, CHEN W Y, et al. Chronic graft-versus-host disease induces murine lupus nephritis model[J]. Chin J Nephrol, 2000, 16(5):277-281. doi:10.3760/j.issn:1001-7097.2000.05.001.
[10]	LIAO Z, HE L, FU J, et al. Identification of novel biomarkers for lupus nephritis[J]. Biomol Biomed, 2025, 25(2):406-424. doi:10.17305/bb.2024.10450.
[11]	WANG S, WEN X, HAN X R, et al. Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy[J]. Cell Prolif, 2018, 51(5):e12462. doi:10.1111/cpr.12462.
[12]	LI J, SHEN J, ZHAO Y, et al. Role of miR‑181a‑5p in cancer (review)[J]. Int J Oncol, 2023, 63(4):108. doi:10.3892/ijo.2023.5556.
[13]	LIU H, DENG Y, LUO G, et al. DNA methylation of miR-181a-5p mediated by DNMT3b drives renal interstitial fibrosis developed from acute kidney injury[J]. Epigenomics, 2024, 16(13):945-960. doi:10.1080/17501911.2024.2370229.
[14]	LIANG X, XU W. miR-181a-5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6[J]. Exp Ther Med, 2020, 20(2):1121-1128. doi:10.3892/etm.2020.8780.
[15]	ABDEL-KADER M S, ABDEL-RAHMAN R F, SOLIMAN G A, et al. Oleuropein relieves pancreatic ischemia reperfusion injury in rats by suppressing inflammation and oxidative stress through HMGB1/NF-κB pathway[J]. Int J Mol Sci, 2024, 25(18):10171. doi:10.3390/ijms251810171.
[16]	李娜, 石宛鑫, 隋满姝. HMGB1与狼疮性肾炎[J]. 中国中西医结合肾病杂志, 2018, 19(2):177-179.
	LI N, SHI W X, SUI M S. HMGB1 and lupus nephritis[J]. Chin J Integ Trad Western Med Nephrol, 2018, 19(2):177-179. doi:10.3969/j.issn.1009-587X.2018.02.031.
[17]	杜艺, 梁顺, 魏玉婷, 等. HMGB1,TNFAIP3蛋白对狼疮性肾炎系膜细胞增殖的影响及其NF-κB信号通路机制[J]. 临床和实验医学杂志, 2020, 19(20):2146-2150.
	DU Y, LIANG S, WEI Y T, et al. Analysis of effect of HMGB1 and TNFAIP3 on proliferation of mesangial cells in lupus nephritis and the mechanism NF-κB signaling pathway[J]. J Clin Experiment Med, 2020, 19(20):2146-2150. doi:10.3969/j.issn.1671-4695.2020.20.006.
[18]	IMAM F, AFZAL M, GHABOURA N, et al. Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway[J]. Saudi Pharm J, 2024, 32(1):101926. doi:10.1016/j.jsps.2023.101926.

引物名称		引物序列（5′→3′）	产物大小/bp
miR-181a-5p	上游：	TCGACCGTTGTACCCT	113
	下游：	TCGACTGCATAGCTAGCTCA	113
HMGB1	上游：	AGCAATCTGAACGTCTGTCC	107
	下游：	GTTCTTGTGATAGCCTTCGC	107
U6	上游：	CTCGCTTCGGCAGCACATA	134
	下游：	AACGATTCACGAATTTGCGT	134
β-actin	上游：	AAGACCTCTATGCCAACACAG	107
	下游：	GGAGGAGCAATGATCTTGATC	107

引物名称		引物序列（5′→3′）	产物大小/bp
miR-181a-5p	上游：	TCGACCGTTGTACCCT	113
	下游：	TCGACTGCATAGCTAGCTCA	113
HMGB1	上游：	AGCAATCTGAACGTCTGTCC	107
	下游：	GTTCTTGTGATAGCCTTCGC	107
U6	上游：	CTCGCTTCGGCAGCACATA	134
	下游：	AACGATTCACGAATTTGCGT	134
β-actin	上游：	AAGACCTCTATGCCAACACAG	107
	下游：	GGAGGAGCAATGATCTTGATC	107

组别	增殖率/ %		凋亡率/ %		miR-181a -5p		HMGB1 mRNA
对照组	100.00±0.00		25.38±2.54		1.00±0.00		1.00±0.00
空白组	156.68±15.65^a		24.34±2.43		0.63±0.07^a		2.12±0.22^a
mimics-NC组	149.34±14.50^a		24.42±2.44		0.62±0.07^a		2.18±0.22^a
miR-181a-5p mimics组	99.03±9.91^b		25.43±2.54		0.89±0.09^b		1.42±0.15^b
Si-NC组	149.64±14.51		24.28±2.26		0.64±0.07		2.16±0.22
Si-HMGB1组	98.83±9.89^c		25.44±2.54		0.67±0.07		1.51±0.16^c
F	34.970^＊＊		0.343		34.176^＊＊		45.326^＊＊
组别		HMGB1/ β-actin		IκB-α/ β-actin		NF-κB p65/ β-actin
对照组		0.35±0.03		1.05±0.10		0.29±0.03
空白组		0.98±0.09^a		0.41±0.04^a		1.01±0.10^a
mimics-NC组		0.96±0.09^a		0.43±0.04^a		0.98±0.09^a
miR-181a-5pmimics组		0.62±0.06^b		0.68±0.07^b		0.61±0.06^b
Si-NC组		0.97±0.09		0.39±0.04		0.95±0.09
Si-HMGB1组		0.58±0.06^c		0.65±0.07^c		0.63±0.06^c
F		77.985^＊＊		93.800^＊＊		85.214^＊＊

组别	增殖率/ %		凋亡率/ %		miR-181a -5p		HMGB1 mRNA
对照组	100.00±0.00		25.38±2.54		1.00±0.00		1.00±0.00
空白组	156.68±15.65^a		24.34±2.43		0.63±0.07^a		2.12±0.22^a
mimics-NC组	149.34±14.50^a		24.42±2.44		0.62±0.07^a		2.18±0.22^a
miR-181a-5p mimics组	99.03±9.91^b		25.43±2.54		0.89±0.09^b		1.42±0.15^b
Si-NC组	149.64±14.51		24.28±2.26		0.64±0.07		2.16±0.22
Si-HMGB1组	98.83±9.89^c		25.44±2.54		0.67±0.07		1.51±0.16^c
F	34.970^＊＊		0.343		34.176^＊＊		45.326^＊＊
组别		HMGB1/ β-actin		IκB-α/ β-actin		NF-κB p65/ β-actin
对照组		0.35±0.03		1.05±0.10		0.29±0.03
空白组		0.98±0.09^a		0.41±0.04^a		1.01±0.10^a
mimics-NC组		0.96±0.09^a		0.43±0.04^a		0.98±0.09^a
miR-181a-5pmimics组		0.62±0.06^b		0.68±0.07^b		0.61±0.06^b
Si-NC组		0.97±0.09		0.39±0.04		0.95±0.09
Si-HMGB1组		0.58±0.06^c		0.65±0.07^c		0.63±0.06^c
F		77.985^＊＊		93.800^＊＊		85.214^＊＊

组别	增殖率/ %		凋亡率/ %		HMGB1/ β-actin
mimics-NC+pcDNA-NC组	156.36±15.64		24.34±2.43		0.86±0.08
miR-181a-5p mimics+ pcDNA-NC组	95.32±9.53^a		25.52±2.52		0.38±0.04^a
mimics-NC+pcDNA-HMGB1组	192.43±19.24^a		24.42±2.39		1.08±0.11^a
miR-181a-5p mimics+ pcDNA-HMGB1组	159.35±16.04^bc		24.37±2.44		0.88±0.08^bc
F	40.836^＊＊		0.329		79.940^＊＊
组别		IκB-α/ β-actin		NF-κB p65/ β-actin
mimics-NC+pcDNA-NC组		0.43±0.04		0.82±0.08
miR-181a-5p mimics+pcDNA-NC组		0.98±0.09^a		0.32±0.03^a
mimics-NC+pcDNA-HMGB1组		0.21±0.02^a		0.98±0.09^a
miR-181a-5p mimics+pcDNA-HMGB1组		0.41±0.04^bc		0.78±0.08^bc
F		223.778^＊＊		88.477^＊＊